Idiopathic thrombocytopenic purpura and the drug abciximab both target platelet membrane glycoprotein IIb-IIIa. ITP is an immune destruction of platelets. Besides being impossible to pronounce, abciximab is used in patients undergoing percutaneous coronary intervention, and is an antiplatelet agent.
The MacBook Neo Is Here to Disrupt the Personal Computing Market
-
A $499 MacBook is a dangerous prospect—if you're a company making Windows
machines.
1 day ago
Posts
quick question, doesnt idiopathic mean we dont know whats causing the dz? How can this be idiopathic, if we know its due to immune destruction?
ReplyDelete